Ruben Schep

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Transcription Factor

Histone Deacetylase

Coronary Artery Disease

Top Venues

Nucleic acids research

This page only lists publications with an associated author ORCID identifier.

Publications

Ruben Schep, Max Trauernicht, Xabier Vergara, Anoek Friskes, Ben Morris, Sebastian Gregoricchio, Stefano G Manzo, Wilbert Zwart, Roderick L Beijersbergen, René H Medema, Bas van Steensel
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing. Nucleic acids research 52 (15) (2024)
Ruben Schep, Max Trauernicht, Xabier Vergara, Anoek Friskes, Ben Morris, Sebastian Gregoricchio, Stefano G Manzo, Wilbert Zwart, Roderick L Beijersbergen, René H Medema, Bas van Steensel
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing. Nucleic acids research (2024)
Ruben Schep, Max Trauernicht, Xabier Vergara, Anoek Friskes, Ben Morris, Sebastian Gregoricchio, Stefano G Manzo, Wilbert Zwart, Roderick L Beijersbergen, René H Medema, Bas van Steensel
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing. Nucleic acids research 52 (15) (2024)
Ruben Schep, Max Trauernicht, Xabier Vergara, Anoek Friskes, Ben Morris, Sebastian Gregoricchio, Stefano G Manzo, Wilbert Zwart, Roderick L Beijersbergen, René H Medema, Bas van Steensel
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing. Nucleic acids research 52 (15) (2024)
Ruben Schep, Max Trauernicht, Xabier Vergara, Anoek Friskes, Ben Morris, Sebastian Gregoricchio, Stefano G Manzo, Wilbert Zwart, Roderick L Beijersbergen, René H Medema, Bas van Steensel
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing. Nucleic acids research (2024)